cardiovascular benefits of glp-1 agonists Receptor for the Reduction Atherosclerotic Risk in Patients With Type 2 Diabetes Glucagon-like peptide 1 receptor agonists:

PHILADELPHIA While celebrities and diabetes patients alike have heralded the swift success of Ozempic and similar drugs, more than 900 complaints...

Its predominant action is on the postprandial glucose levels, with extraglycemic effects on fat metabolism and endovascular function

Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone

- **Curb appetite:** Helping individuals feel full, potentially leading to reduced food intake

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis